Best price Pure 99% Dulaglutide Powder with high quatity CAS NO 923950-08-7.
TDS 6 Inquiries
2805997-46-8
Pharmaceutical Grade
99%
HongKong
customizable
10 bottles per box
2026-09-07
GHK-CU,RETATRUTIDE
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
Survodutide
Other Name:Survodutide;BI 456906;Survodutide Peptide;Survodutide(BI 456906) 10MG;Survodutide acetate;Suvorouti;Swertide peptide;Suvodutide
CAS No.:2805997-46-8
Molecular Weight:0
EC Number:997-146-8
Color/Form:White to off-white
Categories:
Research-
Class:
GLP-1 receptor agonist (GLP-1 analog fused to human IgG4-Fc, long-acting)
Status:FDA-approved (Trulicity 2014)
Mechanism:A long-acting GLP-1 receptor agonist consisting of a modified human GLP-1 molecule (7-37) covalently linked to a modified human IgG4 Fc fragment via a small peptide linker. The Fc fusion extends the half-life to ~5 days, allowing once-weekly dosing. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying.
Activity note:Dulaglutide is a dual-agonist with GLP-1R activation. The exact EC50 is proprietary; functional potency is comparable to other long-acting GLP-1R agonists.
Source:DrugBank: DB09095; PubChem CID 16135271.
Clinical Development:FDA:Trulicity (approved 2014-09-18)
References-
DrugBank:PubChem:Disclaimer:
Dulaglutide is FDA-approved as a prescription medicine (Trulicity) for type 2 diabetes. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GHK-CU,RETATRUTIDE
-
Location:
Guangzhou Changkai Trading Co., Ltd.
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
5
-
Total Employees:
Less than 5
-
Year of Establishment:
2026
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted
United States
Survodutide cas 2805997-46-8
2 MT Nov 14, 2025
United States
Survodutide
10 MG Oct 7, 2024
United States
Survodutide 10MG
10 MG Nov 17, 2025
Ecuador
Survodutide
10 MG Jun 17, 2026
United States
urvodutide
10 G Aug 10, 2025
Bangladesh
Survodutide
1 KG Jul 3, 2024 Post an enquiry for this product